About Multicentric osteolysis-nodulosis-arthropathy spectrum
Multicentric osteolysis-nodulosis-arthropathy spectrum is a rare disease catalogued by Orphanet (ORPHA:371428). It is associated with the MMP2, MMP14 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Multicentric osteolysis-nodulosis-arthropathy spectrum trials.
Search ClinicalTrials.gov for "Multicentric osteolysis-nodulosis-arthropathy spectrum" or filter by Orphanet code ORPHA:371428 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Multicentric osteolysis-nodulosis-arthropathy spectrum trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Multicentric osteolysis-nodulosis-arthropathy spectrum. Updated daily.